Szabo A

NORMENT, Institute of Clinical Medicine, University of Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

7 papers · 2 preprints · ORCID

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

PreprintPsychedelics

The non-classic psychedelic muscimol suppresses inflammatory signaling and promotes neuroplasticity in schizophrenia-derived human cortical spheroids and astroglia

Akkouh IA, Osete JR, Ueland T +4

PreprintPsychedelics

Syner-G: Antidepressant action of psychedelics at the glutamatergic interface of brain, behavior and the immune system

Mason N, Mallaroni P, Szabo A +1

The protective effect of DMT against neurodegeneration.

Frecska E, Kovács A, Szabo A

ArticlePsilocybin

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.

Burmester DR, Madsen MK, Szabo A +7

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).

Reckweg JT, Uthaug MV, Szabo A +4

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.

Szabo A

Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.

Szabo A, Kovacs A, Frecska E +1